Ryan D'Arcy

The Lark Group developed the Health and Technology District in anticipation of the rapidly growing health and technology sector in British Columbia. The District currently consists of three buildings, City Centre 1, 2, and 3, with the largest City Centre 4 breaking ground in 2022 and is slated to be completed in 2025.

D'Arcy has been named one of Business in Vancouver's 2021 and 2022 BC500 leaders, recognizing the 500 most influential business leaders in British Columbia.

In 2021, D'Arcy was named Business Person of the Year at the 2021 Surrey Board of Trade, Surrey Business Excellence Award.

D’Arcy and his research team at HealthTech Connex Inc. and the Surrey Neuroplasticity Clinic in Surrey, B.C., continued to help Greene with intensive daily rehabilitation, but the team experienced an extended plateau in progress using conventional therapy alone. To break through the plateau, the research team launched an intensive 14-week study using the Portable Neuromodulation Stimulator (or PoNS™), in combination with physical therapy to safely stimulate novel neuroplasticity and tracked brain vital sign improvements using the NeuroCatch® Platform (or NeuroCatch®). The peer-reviewed study on Capt. Greene’s physical, cognitive and PTSD improvements was published in September 2020 in the Frontiers of Human Neuroscience, demonstrating that the PoNS neurostimulation, paired with intensive rehabilitation, may stimulate neuroplasticity to overcome an extended recovery plateau in this case as objectively measured by NeuroCatch and other brain scanning technologies.

In 2019, D'Arcy spearheaded the formation of BrainNET within the Health and Technology District, a clinical-academic-innovation network dedicated to bringing advances in neuro-technologies to individual improvements in brain health through a consortium of initiatives and technologies.

D'Arcy's HealthTech Connex Inc. team won a 2018 Surrey Business Excellence Award from the Surrey Board of Trade.

D’Arcy's team was awarded the International Global Best Award in STEM in 2016 (Science, Technology, Engineering, and Mathematics).

In 2013, D’Arcy and Kirk Fisher co-founded HealthTech Connex Inc. Derived from the brain vital sign science, HealthTech Connex conceived the NeuroCatch Platform to convert electroencephalography recordings (EEG) of the N100 (Auditory sensation), P300 (Basic attention), and N400 (Cognitive processing) into a rapid, portable, non-invasive evaluation platform for point-of-care deployment.

D’Arcy was involved with Simon Fraser University's rapid growth in medical technology research, one component of which is the launch of the ImageTech Lab. The SFU ImageTechLab is a first-of-its-kind research facility in Western Canada, combining state-of-the-art imaging devices to advance brain/body research, and focus on advanced diagnostics and treatment in neurology, mental health and other healthcare areas. The ImageTech Lab completed the large-scale initiative announced April 2013 by then City of Surrey Mayor Dianne Watts to create the Mayor's Health Technology Working Group with D’Arcy as co-chair. It composed of leaders from the health, education and development communities to shape a new health-tech region located between Simon Fraser University Surrey and Surrey Memorial Hospital called Innovation Boulevard.

Since 2009, D’Arcy has been helping rehabilitate Trevor Greene, a Canadian war veteran and brain injury survivor who was attacked while on tour in Afghanistan with an axe to the head. D'Arcy, together with Trevor and his wife Debbie Greene, have used different modalities to support recovery through the use of brain imaging, assistive device, and neuromodulation technologies paired with intensive rehabilitation. The project (called “Iron Soldier”) has since progressed towards Trevor's goal to climb to the Mount Everest base camp, and catalyzed the Legion Veteran's Village initiative to revitalize Legions across the country into centres for excellence in rehabilitation and post-traumatic stress disorder.

In 2008, together with neuroscientist and neurosurgeon Dr. David B. Clarke, D'Arcy was part of the research team at the National Research Council at Dalhousie University in developing the world's first virtual reality based neurosurgical simulation and rehearsal tool NeuroTouch, which was subsequently licensed to CAE Inc. as NeuroVR. Subsequently, D'Arcy and Clarke teamed up again, this time with Conquer Mobile to develop PeriopSim, a suite of portable surgical simulation training tools used to train perioperative nurses.

Foundational research that led to the concept of brain vital signs started in 1995, with Dr. D’Arcy leading the development of the first rapid, easy, point-of-care measurement of brain waves in 2011. The objective was to utilize electroencephalography (EEG) data, and particularly cognitive evoked potentials (EPs), also known as event-related potentials (ERPs), as an objective physiological measure of brain function. ERPs were well established but had not been translated into a clinically accessible framework in a manner similar to the measurement of a body's vital signs like blood pressure. D’Arcy’s team developed a new brain vital sign framework specific to the evaluation and monitoring of brain function. The brain vital signs framework, which derived from the earlier Halifax Consciousness Scanner work, objectively analyze complex EEG data, which then provides simple and objective physiological markers of brain function.

Since 1995, D’Arcy and his research team have led the development of using event-related potentials (ERPs) for clinical evaluations of brain function. In 2010, they developed the Halifax Consciousness Scanner (HCS), a portable ERP device that quickly determines neurological function in cases of severe brain trauma. The HCS technology was widely recognized with several innovation awards, including the 2015 Winner of Wall Street Journal’s Global Technology Start-up Showcase. While developed for functional status evaluation, the HCS prototype ultimately led to the discovery of the brain vital signs framework, which has since led the development the NeuroCatch Platform through HealthTech Connex. The NeuroCatch Platform received its first regulator approval as a Class II Medical Device from Health Canada in early 2019.

Born and raised in Williams Lake, British Columbia, Ryan D'Arcy attended Brentwood College School, on Vancouver Island, graduating in 1990. He earned a B.Sc. (with distinction) from the University of Victoria in 1996, an M.Sc. in neuropsychology in 1998 and a Ph.D. in neuroscience in 2002 from Dalhousie University. D'Arcy was a Killam Scholar while at Dalhousie University. In 2001, he moved to NRC’s Institute for Biodiagnostics for a Research Associate/Postdoctoral Fellowship in Magnetic Resonance Imaging Physics. He is a member of the Professional Engineers and Geoscientists of British Columbia, as an engineering licensee (PlEng) with a specialization in neuroimaging and neurotechnology.

In the early 1990s, using functional MRI to detect white matter was considered controversial, despite it being traditionally used for gray brain matter. Dr. D’Arcy and a team of researchers set out to investigate white matter fMRI activation, and published a number of studies with evidence to support using fMRI for white matter activation. These studies opened up fundamental avenues to explore functional connectivity in distributed neural networks, which has since been used to advance understanding of white matter dysfunction in neurological diseases such as multiple sclerosis and Alzheimer’s disease.

Ryan C.N. D'Arcy (born 1972) is a Canadian neuroscientist, researcher, innovator and entrepreneur. D'Arcy co-founded HealthTech Connex Inc. and serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advances into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework.